SCHEMBL4655464

SCHEMBL4655464

O=C(O)CC[C@H](NCCO)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 7/20 0.55
NAALAD2 Q9Y3Q0 2/20 0.55
RIMKLA Q8IXN7 1/20 0.55
GGH Q92820 1/20 0.47
GGT1 P19440 1/20 0.42
TET2 Q6N021 3/20 0.41
KDM4A O75164 2/20 0.41
KDM4C Q9H3R0 2/20 0.41
KDM2A Q9Y2K7 2/20 0.41
TET3 O43151 1/20 0.41
CYP1A2 P05177 2/20 0.40
GRM8 O00222 1/20 0.40
GRM6 O15303 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GSR P00390 1/20 0.40
GRIK1 P39086 1/20 0.40
GRM5 P41594 1/20 0.40
GRIA1 P42261 1/20 0.40
GRIA2 P42262 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2450582 1.00 FOLH1 (0.55) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL8140077 0.90 FOLH1 (0.53) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL141783 0.89 FOLH1 (0.61) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL29356795 0.89 FOLH1 (0.61) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL8768068 0.89 FOLH1 (0.61) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL8769194 0.89 FOLH1 (0.61) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL27868855 0.88 FOLH1 (0.52) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL1286834 0.88 FOLH1 (0.52) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL147131 0.87 FOLH1 (0.59) FOLH1NAALAD2RIMKLAGGHGGT1
SCHEMBL27698275 0.87 FOLH1 (0.59) FOLH1NAALAD2RIMKLAGGHGGT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117460710-A Amino acid cationic lipid 厦门赛诺邦格生物科技股份有限公司 2024-01-26 CN disclosed
CN-105899515-B Derivatives of uncialamycin, method of synthesis and use thereof as antitumor agents 威廉马歇莱思大学 2020-01-14 CN disclosed
CN-106132456-B Apparatus, solution and method for sample collection 阿波根有限公司 2019-12-24 CN disclosed
EP-1392755-B1 LIPID-POLYMER-CONJUGATES COMPOSITIONS ASTELLAS PHARMA EUROP B V (NL) 2008-12-03 EP disclosed
US-20040241222-A1 Lipid-polymer-conjugates compositions ASTELLAS PHARMA EUROPE B.V. (NL) 2004-12-02 US disclosed
EP-1392755-A1 LIPID-POLYMER-CONJUGATES COMPOSITIONS YAMANOUCHI EUROPE B.V. (NL) 2004-03-03 EP disclosed
WO-2002098952-A1 LIPID-POLYMER-CONJUGATES COMPOSITIONS YAMANOUCHI EUROPE B.V. (NL) 2002-12-12 WO disclosed
EP-1189971-A2 FUNCTIONAL POLY-ALPHA-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION UNIVERSITEIT GENT (BE) 2002-03-27 EP disclosed
WO-2000078791-A2 FUNCTIONAL POLY-α-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION UNIVERSITEIT GENT (BE) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040241222-A1 Lipid-polymer-conjugates compositions PHOSPHO1, PARG, GLUL FOLH1 108/4885NAALAD2 312/4885RIMKLA 360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.